Abstract: The present invention relates to novel JP170 like subtilases from wild-type bacteria, hybrids thereof and to methods of construction and production of these proteases. Further, the present invention relates to use of the claimed subtilases in detergents, such as a laundry or an automatic dishwashing detergent.

Abstract: The present invention relates to a method for producing an acidified milk drink using an enzyme which reduces the isoelectric point of the milk proteins. The invention also relates to a novel enzyme having deamidase activity and its use in production of an acidified milk drink.

Abstract: The present invention relates to novel JP170 like subtilases from wild-type bacteria, hybrids thereof and to methods of construction and production of these proteases. Further, the present invention relates to use of the claimed subtilases in detergents, such as a laundry or an automatic dishwashing detergent.

Abstract: A new strain Bacillus sp. P203 (Bacillus plakortiensis) is disclosed. Isolated mature functional polypeptide which is obtainable from the bacterium strain Bacillus sp. P203 deposited under accession number DSM 17419 are disclosed.

Abstract: The present invention relates to novel subtilases from wild-type strains of Bacillus, especially the Bacillus strains ZI344, EP655, P203, EP63, ZI120, ZI130, ZI1342 and ZI140, and to methods of construction and production of these proteases. Further, the present invention relates to use of the claimed subtilases in detergents, such as a laundry detergent or an automatic dishwashing detergent.

Abstract: The present invention relates to an isolated mutant eubacterium comprising at least one mutation resulting in a substitution of at least one amino acid in the beta-subunit of the RNA-polymerase encoded for by the rpoB-gene providing an altered production of a product of interest when said production of a product of interest is compared to the production of the same product in an isogenic wild type strain grown at identical conditions, wherein the substitution of at least one amino acid occurs at any of positions 469, 478, 482, 485, or 487 of SEQ ID NO:2, or at the equivalent positions in any eubacterial RNA-polymererase beta-subunit family member. Another aspect of the invention relates to a process for producing at least one product of interest in a mutant eubacterium and to a use of the mutant eubacterium according to the invention for producing at least one product of interest.

Abstract: The present invention relates to novel subtilases from wild-type strains of Bacillus, especially the Bacillus strains ZI344, EP655, P203, EP63, ZI120, ZI130, ZI1342 and ZI140, and to methods of construction and production of these proteases. Further, the present invention relates to use of the claimed subtilases in detergents, such as a laundry detergent or an automatic dishwashing detergent.

Abstract: The present invention relates to novel JP170 like subtilases from wild-type bacteria, hybrids thereof and to methods of construction and production of these proteases. Further, the present invention relates to use of the claimed subtilases in detergents, such as a laundry or an automatic dishwashing detergent.

Abstract: The present invention relates to a medication delivery device for expelling set doses of medicament, the medication delivery device comprising a position determining assembly for detecting absolute positions of a rotatably mounted member arranged within the device, the position determining assembly comprising a plurality of transmitter electrodes arranged on a first exterior surface part of the rotatably mounted member, a plurality of receiver electrodes arranged on a second exterior surface part of the rotatably mounted member. A number of transmitter electrodes form pairs of interconnected electrodes with a number of receiver electrodes. A reading assembly fixedly arranged relative to for example the housing of the medication delivery device is also provided.

Abstract: The present Invention relates to an injection device capable of emitting a flashing light signal indicating the time elapsed since last ejection and/or the size of the last ejected dosage and/or a return signal indicating the operable state of the device and/or a time out signal indicating when the pen can be removed after ejecting of a dosage. The injection device comprises an electronic control circuit comprising: a sensor unit arranged to detect the occurrence of an ejection of a drug from the injection device; a timer for determining an approximate time elapsed since last ejection; a signal emitting device being able to emit a signal, the signal emitting device being controllable by the electric control circuit, so as to emit a time signal that varies with the time elapsed since last ejection.

Abstract: The present invention relates to a contact free arrangement for determining an absolute position of a member adapted for setting an amount of medicament to be injected from a medication delivery device, or adapted for determining an amount of medicament injected from a medication delivery device. The arrangement according to the present invention comprises at least one track of reflector means, at least one emitter means, and at least one receiver means. The at least one emitter means and the at least one receiver means are adapted to electrically couple to a number of the reflector means. The electrical coupling may be capacitive or inductive. In addition, the present invention relates to a medication delivery device or a syringe having such arrangement.

Abstract: The present invention relates to novel JP170 like subtilases from wild-type bacteria, hybrids thereof and to methods of construction and production of these proteases. Further, the present invention relates to use of the claimed subtilases in detergents, such as a laundry or an automatic dishwashing detergent.

Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.

Abstract: A medication delivery device comprises an injection device having a reservoir comprising a medicament to be ejected, and a sensor arranged to detect an ejection of the medicament from the injection device, the sensor being arranged to output a signal comprising ejecting information, and a processor for collecting and storing the ejection information.

Abstract: The present invention relates to novel JP170 like subtilases from wild-type bacteria, hybrids thereof and to methods of construction and production of these proteases. Further, the present invention relates to use of the claimed subtilases in detergents, such as a laundry or an automatic dishwashing detergent.

Abstract: A medication delivery system, comprising: a movable part (230, 232) adapted to move relative to a stationary part; at least two conductors (234, 236) which are arranged such that an electrical characteristic is defined by the mutual position of the movable and the stationary part and/or by movement of one of said parts relative to the other; and a detector for detecting a change of said electrical characteristic, wherein the parts are stationary relative to each other during dose setting and in that the parts are moved relative to each other during dose ejection, such that that detector provides a signal indicative of the actual amount of the ejected dose.

Abstract: The present invention relates to novel subtilases from wild-type strains of Bacillus, especially the Bacillus strains ZI344, EP655, P203, EP63, ZI120, ZI130, ZI1342 and ZI140, and to methods of construction and production of these proteases. Further, the present invention relates to use of the claimed subtilases in detergents, such as a laundry detergent or an automatic dishwashing detergent.

Abstract: This invention relates to a container (10) for a medication delivery (110) device comprising an optical reader (111), where said container comprises a code information element (20) carrying a set of information readable by said optical reader where the container comprises at least one more code information element (20) carrying the set of information readable by said optical reader. The invention further relates to a method of applying code information elements onto the container and to a method of reading a code information element. The code information elements can be aligned with at least one protrusion on the container, or are aligned with at least one cavity on the container. Alternatively or additionally, the code information elements are juxtaposed to one another. Hereby, an optical code reader, embedded in the medication delivery device, will be able securely to read the information carried by means of image processing software compiling and combining more code information elements.

Abstract: The present invention relates to a method for screening for compounds secreted by an organism, comprising (a) raising antibodies against secreted products of a donor organism, (b) providing a gene library from the donor organism, (c) cloning the gene library into a suitable host organism, (d) expressing the cloned genes in the host organism, and (e) detecting positive clones, which upon expression of the cloned genes secretes a compound, using the antibodies of (a) to identify such positive clones. The invention also relates to compounds, nucleotide sequences and microorganisms identifiable by said method.

Abstract: The invention relates to a marking of cartridges, carpules or any kind of package. The marking can be in an electronically readable form while being transparent. Hereby a marking with improved security for avoiding reading errors which ensures a mandatory visual inspection of content is obtained. The transparent conductor can be in form of a polymer, an ITO and the like. These transparent conductors are used in an improved marking technique, which further improves reading security. The invention may e.g. be used in connection with medication delivery devices for self-treatment of a disease, e.g. diabetes.